🇺🇸 FDA
Patent

US 10570186

Chimeric antigen receptors (CAR) to selectively target protein complexes

granted A61KA61K2039/505A61P

Quick answer

US patent 10570186 (Chimeric antigen receptors (CAR) to selectively target protein complexes) held by The Board of Regents of the University of Texas System expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61P, A61P35/00